Mode
Text Size
Log in / Sign up

SHAP-based model predicts pneumonia after aneurysmal subarachnoid hemorrhage embolization

SHAP-based model predicts pneumonia after aneurysmal subarachnoid hemorrhage embolization
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider this SHAP-based model as a preliminary tool for predicting post-embolization pneumonia in aSAH, noting it requires external validation.

This was a retrospective cohort study at Huizhou Central People's Hospital involving 290 patients with aneurysmal subarachnoid hemorrhage (aSAH). The study aimed to predict postoperative stroke-associated pneumonia (SAP) within 14 days after endovascular embolization. No specific intervention or comparator was reported.

The main result was that a random forest (RF) model with SHAP interpretation showed stable performance and good efficacy in both training and validation sets. The nomogram model also had good predictive performance, a low error rate, and significant clinical benefits. The absolute number of patients analyzed was 290.

Safety and tolerability were not reported; no adverse events, serious adverse events, or discontinuations were noted. Key limitations include the retrospective design, single-center setting, and exclusion of 85 patients due to exclusion criteria.

The practice relevance suggests that an SHAP interpretable prediction model may provide clinical reference value for reducing complication burden. However, the association is only predictive; causation is not established, and findings are preliminary from a retrospective cohort requiring external validation.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundAneurysmal subarachnoid hemorrhage (aSAH) is a neurological emergency characterized by intracranial aneurysm rupture, leading to blood influx into the subarachnoid space and imposing high mortality and disability rates. The aim of this study was combining the epidemiological characteristics of aSAH and the high incidence of stroke-associated pneumonia (SAP), we aimed to develop a SHAP-explainable prediction model that may provide clinical reference value, providing a new approach to reduce the burden of complications. We take the random forest (RF) model combined with SHAP interpretation as the primary predictive model, and the logistic regression-based nomogram as a supplementary transparent tool for clinical bedside application.MethodsA retrospective analysis was conducted in aSAH patients at Huizhou Central People’s Hospital. The patients were randomly split into training and validation sets for methodological purposes to generate and validate a SHAP interpretable machine learning model.ResultsA total of 375 patients were initially enrolled, with 85 excluded due to exclusion criteria, leaving 290 patients for retrospective analysis. Univariate logistic regression, LASSO regression, and Boruta algorithm were used for multivariable feature selection and the common factors across the three methods were lactate dehydrogenase (LDH, SIRI, BMI, Age, AST, D-Dimer, and Hunt–Hess score). We established a nomogram model with good predictive performance, low error rate, and significant clinical benefits. The RF model showed stable performance and good efficacy in both training and validation sets. Based on the RF model, SHAP analysis was conducted to evaluate risk factor importance and individual impacts. The RF model with SHAP interpretation was identified as the primary predictive model, while the nomogram served as a supplementary transparent tool.ConclusionThis study identifies postoperative stroke-associated pneumonia [stroke-associated pneumonia (SAP)] within 14 days after endovascular embolization BMI, Age, SIRI, Hunt–Hess score, D-Dimer, AST, and lactate dehydrogenase LDH as key predictors of postoperative stroke-associated pneumonia (SAP) in aSAH, and demonstrates the efficient performance of the RF random forest model (with SHAP interpretation) in prediction.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.